(Q73109985)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532516%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Effects of fluvastatin on prothrombotic and fibrinolytic factors in type 2 diabetes mellitus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532516%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

K C Tan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532516%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

E D Janus

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532516%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

K S Lam

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532516%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

English

0 references

publication date

1 October 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532516%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532516%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532516%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532516%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

934-7, A7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532516%20AND%20SRC:MED&resulttype=core&format=json

Genetic influence of the R/Q353 genotype on factor VII activity is overwhelmed by environmental factors in Chinese patients with Type II (non-insulin-dependent) diabetes mellitus

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900471-3

Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900471-3

Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900471-3

The fibrinolytic system in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900471-3

Vastatins Inhibit Tissue Factor in Cultured Human Macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900471-3

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900471-3

Von Willebrand factor and soluble E-selectin in hyperlipidaemia: relationship to lipids and vascular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900471-3

Randomized placebo-controlled study of the effects of simvastatin on haemostatic variables, lipoproteins and free fatty acids. The Oxford Cholesterol Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900471-3

Effect of Fluvastatin on Lipids and Fibrinolysis in Coronary Artery Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900471-3

Simvastatin in non-insulin-dependent diabetes mellitus: effect on serum lipids, lipoproteins and haemostatic measures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900471-3

Activation of coagulation factor VII during alimentary lipemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900471-3

von Willebrand factor: a marker of endothelial dysfunction in vascular disorders?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900471-3

Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs. An LDL receptor-independent phenomenon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900471-3

Lipoproteins inhibit the secretion of tissue plasminogen activator from human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900471-3

Lipoproteins and thrombosis: effects of lipid lowering.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900471-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(99)00471-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532516%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference